Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a modified camera capture better images of diseased retinas?

NCT ID NCT07796230

Knowledge-focused Sponsor: Optos, PLC Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 01, 2026 · Last updated Sep 02, 2026 · Updated 1 time

Summary

This study tests a modified P200TE imaging device to see how well it captures images of the retina in people with posterior segment eye diseases, such as age-related macular degeneration, glaucoma, and diabetic retinopathy. Researchers will collect images from 50 adults with these conditions to evaluate the device's performance. The goal is to gather data that could support the device's use in clinical practice.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A modified P200TE imaging device used to capture retinal images
What this could lead to
If the device works well, it could lead to better imaging tools for diagnosing and monitoring retinal diseases.
What could go wrong
This is a small, early-stage data collection study, so it may not prove the device's clinical value. Image quality or usability issues could limit its use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2026

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Participants with eye disease seen at a US clinical site

Ages

22 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria Male or female participants 22 years of age or older who have full legal capacity to volunteer on the date the informed consent is signed Participants who can follow the instructions by the clinical staff at the clinical site Participants who agree to participate in the study Participants with posterior segment eye disease. Example of pathologies may include but are not limited to Age-related macular degeneration, glaucoma, diabetic retinopathy, posterior uveitis, central serous chorioretinopathy, vein occlusion, epiretinal membrane and others as confirmed by the investigator. Exclusion Criteria Participants unable to tolerate ophthalmic imaging. Participants with ocular media not sufficiently clear to obtain acceptable images. Unable to obtain acceptable image quality on participant.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Retina disease are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

retinal disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Retina disease

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Bennett & Bloom Eye Centers

    RECRUITING

    Louisville, Kentucky, 40222, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.